Netflix’s global subscribers to cross the much-awaited 100 million mark
Category: #world  By Pankaj Singh  Date: 2017-04-20
  • share
  • Twitter
  • Facebook
  • LinkedIn

Netflix’s global subscribers to cross the much-awaited 100 million mark

Netflix, the famous American entertainment firm, is on the brink of surpassing a global subscriber count of 100 million very soon. Reports cite that the prediction was made after the company’s earnings from the first quarter of 2017 were released and evaluated.

For the uninitiated, Netflix is a video streaming service that helps users watch numerous TV shows and movies. The meteoric rise of Netflix in the entertainment industry can be credited to the increasing penetration of tablets and smartphones across the globe, which have undoubtedly evolved as a major medium for watching videos irrespective of the time or location. The question that has now plagued experts is whether Netflix plans to increase its subscription rates, given that the number of subscribers has exponentially risen? Leading analysts state that the company aims to keep its investors happy, in response to which it might have to enhance its profit margin, which is comparatively low. In any case, the company has not yet released a direct statement pertaining to the rise in prices, as of now.

Netflix has more than 51 million subscribers in the U.S., currently. The end of March witnessed nearly 48 million subscribers outside of the United States. The numbers are expected to significantly rise by the end of the year. From January 2017 to March 2017, the company added almost 5 million subscribers. By the end of March, the service aims to have a nearly 98.7 million subscribers across a geographical expanse of 190 countries. These statistics are an indisputable evidence of how much this media streaming service has affected the global entertainment aspect, quote experts.

Half a decade earlier, Netflix aimed to penetrate every region in the United States, and ultimately across the globe, a goal which has given the company lucrative results, as of today. Netflix’s stock prices have plummeted since the last half a decade, during which time the company had added more than 72 million subscribers.

Netflix has also made efforts to battle arch rival HBO, which already has a praiseworthy 134 million subscribers globally. The monthly subscription fee for Netflix varies between USD 8 to USD 12, a benchmark that has proven successful from the customer perspective, as is evident from the numbers – Netflix’s streaming hours increased to 1 billion per week after the USD 10 per month business model was launched.

Netflix will take a considerably long time to overtake HBO, nonetheless, the prediction to cross 100 million global subscribers is deemed as stepping stone for the future, affirm experts.

Netflix’s growth strategy subject to the increasing number of subscribers includes launching the service in practically every region across the globe. Additionally, the company aims to deliver original, unadulterated content to attract the maximum number of customers, cite sources.



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Flipkart launches Loyalty Program across 5,000 retail outlets in India
Flipkart launches Loyalty Program across 5,000 retail outlets in India
By Pankaj Singh

E-commerce giant Flipkart has recently launched SuperCoin Pay, a system of currency which its customers will have the right to use across tons of retail stores in the country. Flipkart is betting on its loyalty program...

Sirnaomics reveals dose administration of 1st patient in STP705 trial
Sirnaomics reveals dose administration of 1st patient in STP705 trial
By Pankaj Singh

Sirnaomics, Inc., a clinical-stage biopharmaceutical company, has recently announced the dose administration of the 1st patient in a Phase 2a clinical trial of STP705. STP705 is a lead drug candidate develop...

Pfizer’s XALKORI®) Approved by US FDA for ALK-positive ALCL treatment
Pfizer’s XALKORI®) Approved by US FDA for ALK-positive ALCL treatment
By Pankaj Singh

The pharma giant Pfizer Inc. has reportedly declared that the U.S. Food and Drug Administration (US FDA) has approved the sNDA (supplemental New Drug Application) for XALKORI® (crizotinib) for the treatment of chil...